2PM8 - JenaLib

Biol.Unit 1 - manually (Jmol Viewer)

Asymmetric Unit (Jmol Viewer)

Asym. Unit - sites (Jmol Viewer)

Biological Unit 1 (Jmol Viewer)

Biol. Unit 1 - sites (Jmol Viewer)

Title :   CRYSTAL STRUCTURE OF RECOMBINANT FULL LENGTH HUMAN BUTYRYLCHOLINESTERASE

Authors :   M. N. Ngamelue, K. Homma, O. Lockridge, O. A. Asojo

Date :   20 Apr 07 (Deposition) - 25 Sep 07 (Release) - 13 Jul 11 (Revision)

Method :   X-RAY DIFFRACTION

Resolution :   2.80

Chains :   Asym. Unit : A,B,C^#
Biol. Unit 1: A,B  (4x)
( ^#: chains that contain no standard or modified protein/DNA/RNA residue)

Keywords :   Cholinesterase, Hydrolase (Keyword Search: [Gene Ontology, PubMed, Web (Google)] )

Reference :   M. N. Ngamelue, K. Homma, O. Lockridge, O. A. Asojo
Crystallization And X-Ray Structure Of Full-Length Recombinant Human Butyrylcholinesterase.
Acta Crystallogr. , Sect. F V. 63 723 2007
PubMed-ID: 17768338 | Reference-DOI: 10.1107/S1744309107037335

Molecule 1 - CHOLINESTERASE
	Chains	:	A, B
	EC Number	:	3.1.1.8
	Engineered	:	YES
	Expression System	:	CRICETULUS GRISEUS
	Expression System Common	:	CHINESE HAMSTER
	Expression System Taxid	:	10029
	Gene	:	BCHE, CHE1
	Organism Common	:	HUMAN
	Organism Scientific	:	HOMO SAPIENS
	Organism Taxid	:	9606
	Synonym	:	ACYLCHOLINE ACYLHYDROLASE, CHOLINE ESTERASE II, BUTYRYLCHOLINE ESTERASE, PSEUDOCHOLINESTERASE

		1	2	3
Asymmetric Unit	:	A	B	C^#
Biological Unit 1 (4x)	:	A	B

( ^#: chains that contain no standard or modified protein/DNA/RNA residue)

Summary Information (see also Sequences/Alignments below)

Asymmetric Unit (4, 19)

No.	Name	Count	Type	Full Name
1	GOL	5	Ligand/Ion	GLYCEROL
2	NAG	6	Ligand/Ion	N-ACETYL-D-GLUCOSAMINE
3	NDG	1	Ligand/Ion	2-(ACETYLAMINO)-2-DEOXY-A-D-GLUCOPYRANOSE
4	SO4	7	Ligand/Ion	SULFATE ION

Biological Unit 1 (4, 68)

No.	Name	Count	Type	Full Name
1	GOL	20	Ligand/Ion	GLYCEROL
2	NAG	16	Ligand/Ion	N-ACETYL-D-GLUCOSAMINE
3	NDG	4	Ligand/Ion	2-(ACETYLAMINO)-2-DEOXY-A-D-GLUCOPYRANOSE
4	SO4	28	Ligand/Ion	SULFATE ION

Asymmetric Unit (19, 19)

No.	Name	Evidence	Residues	Description
01	AC1	SOFTWARE	SER A:338 , ASN A:341 , ASN A:342 , NAG C:782 , HOH C:783	BINDING SITE FOR RESIDUE NAG C 781
02	AC2	SOFTWARE	GLY A:336 , NAG C:781	BINDING SITE FOR RESIDUE NAG C 782
03	AC3	SOFTWARE	ASN A:106 , ASN A:188 , LYS A:190 , HOH A:1013	BINDING SITE FOR RESIDUE NAG A 791
04	AC4	SOFTWARE	ARG A:465 , ASN A:485 , HOH A:1043	BINDING SITE FOR RESIDUE NDG A 678
05	AC5	SOFTWARE	ARG A:14 , ILE A:55 , ASN A:57 , HOH A:1044	BINDING SITE FOR RESIDUE NAG A 798
06	AC6	SOFTWARE	ASN B:341 , ASN B:342	BINDING SITE FOR RESIDUE NAG B 781
07	AC7	SOFTWARE	ASN B:106 , ASN B:188	BINDING SITE FOR RESIDUE NAG B 791
08	AC8	SOFTWARE	GLN A:316 , ASN A:414 , ASN A:415	BINDING SITE FOR RESIDUE SO4 A 601
09	AC9	SOFTWARE	HIS A:372 , GLN A:517 , ARG A:520 , PHE A:521 , PHE A:525 , LYS B:528	BINDING SITE FOR RESIDUE SO4 A 602
10	BC1	SOFTWARE	SER A:524 , PHE A:525 , LYS A:528 , SER B:524 , PHE B:525 , LYS B:528 , SO4 B:602	BINDING SITE FOR RESIDUE SO4 A 603
11	BC2	SOFTWARE	ASN A:228 , CYS A:400 , PRO A:401 , THR A:523	BINDING SITE FOR RESIDUE SO4 A 604
12	BC3	SOFTWARE	GLN A:351 , LEU A:354 , LYS A:366 , GLU A:367 , LEU A:370	BINDING SITE FOR RESIDUE SO4 A 606
13	BC4	SOFTWARE	GLN B:316 , ASN B:414 , ASN B:415	BINDING SITE FOR RESIDUE SO4 B 601
14	BC5	SOFTWARE	LYS A:528 , SO4 A:603 , GLN B:517 , ARG B:520 , PHE B:521 , PHE B:525	BINDING SITE FOR RESIDUE SO4 B 602
15	BC6	SOFTWARE	LEU A:236 , VAL A:294 , MET A:302	BINDING SITE FOR RESIDUE GOL A 999
16	BC7	SOFTWARE	VAL A:233 , THR A:234 , GLU A:238 , ARG A:242 , VAL A:288	BINDING SITE FOR RESIDUE GOL A 774
17	BC8	SOFTWARE	PHE A:76 , HIS A:77 , THR A:86 , ASP A:87 , PRO A:429	BINDING SITE FOR RESIDUE GOL A 777
18	BC9	SOFTWARE	TRP B:231 , VAL B:233 , THR B:234 , GLU B:238 , ARG B:242 , VAL B:288 , HOH B:802	BINDING SITE FOR RESIDUE GOL B 774
19	CC1	SOFTWARE	PHE B:76 , HIS B:77 , HOH B:823	BINDING SITE FOR RESIDUE GOL B 777

Asymmetric Unit

No.	Residues
1	A:65	-	A:92
2	A:252	-	A:263
3	A:400	-	A:519
4	B:65	-	B:92
5	B:252	-	B:263
6	B:400	-	B:519

Asymmetric Unit

No.	Residues
1	Ala A:101	-	Pro A:102
2	Pro A:104	-	Lys A:105
3	Ala B:101	-	Pro B:102
4	Pro B:104	-	Lys B:105

Asymmetric Unit (42, 84)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_072094	K	40	R	CHLE_HUMAN	Polymorphism	116047990	A/B	K	12	R
02	UniProt	VAR_040012	T	52	M	CHLE_HUMAN	Disease (BChE deficiency)	56309853	A/B	T	24	M
03	UniProt	VAR_040013	F	56	I	CHLE_HUMAN	Disease (BChE deficiency)	531738678	A/B	F	28	I
04	UniProt	VAR_040014	Y	61	C	CHLE_HUMAN	Disease (BChE deficiency)	116097205	A/B	Y	33	C
05	UniProt	VAR_072730	A	62	V	CHLE_HUMAN	Disease (BChE deficiency)	---	A/B	A	34	V
06	UniProt	VAR_040015	P	65	S	CHLE_HUMAN	Disease (BChE deficiency)	148170012	A/B	P	37	S
07	UniProt	VAR_002360	D	98	G	CHLE_HUMAN	Disease (BChE deficiency)	1799807	A/B	D	70	G
08	UniProt	VAR_040016	D	98	H	CHLE_HUMAN	Disease (BChE deficiency)	---	A/B	D	70	H
09	UniProt	VAR_072095	G	103	R	CHLE_HUMAN	Disease (BChE deficiency)	---	A/B	G	75	R
10	UniProt	VAR_072096	E	118	D	CHLE_HUMAN	Disease (BChE deficiency)	---	A/B	E	90	D
11	UniProt	VAR_040017	N	124	Y	CHLE_HUMAN	Disease (BChE deficiency)	---	A/B	N	96	Y
12	UniProt	VAR_072097	I	127	M	CHLE_HUMAN	Polymorphism	755600722	A/B	I	99	M
13	UniProt	VAR_040018	P	128	S	CHLE_HUMAN	Disease (BChE deficiency)	3732880	A/B	P	100	S
14	UniProt	VAR_040019	G	143	D	CHLE_HUMAN	Disease (BChE deficiency)	201820739	A/B	G	115	D
15	UniProt	VAR_040020	L	153	F	CHLE_HUMAN	Disease (BChE deficiency)	747598704	A/B	L	125	F
16	UniProt	VAR_040021	Y	156	C	CHLE_HUMAN	Disease (BChE deficiency)	121918558	A/B	Y	128	C
17	UniProt	VAR_040022	V	170	M	CHLE_HUMAN	Disease (BChE deficiency)	527843566	A/B	V	142	M
18	UniProt	VAR_040023	D	198	E	CHLE_HUMAN	Disease (BChE deficiency)	781368801	A/B	D	170	E
19	UniProt	VAR_040024	S	226	G	CHLE_HUMAN	Disease (BChE deficiency)	370077923	A/B	S	198	G
20	UniProt	VAR_040025	A	227	V	CHLE_HUMAN	Disease (BChE deficiency)	---	A/B	A	199	V
21	UniProt	VAR_040026	A	229	T	CHLE_HUMAN	Disease (BChE deficiency)	---	A/B	A	201	T
22	UniProt	VAR_072098	V	232	D	CHLE_HUMAN	Disease (BChE deficiency)	---	A/B	V	204	D
23	UniProt	VAR_040027	T	271	M	CHLE_HUMAN	Disease (BChE deficiency)	28933389	A/B	T	243	M
24	UniProt	VAR_040028	T	278	P	CHLE_HUMAN	Disease (BChE deficiency)	---	A/B	T	250	P
25	UniProt	VAR_040029	E	283	D	CHLE_HUMAN	Polymorphism	16849700	A/B	E	255	D
26	UniProt	VAR_040030	K	295	R	CHLE_HUMAN	Disease (BChE deficiency)	115624085	A/B	K	267	R
27	UniProt	VAR_072099	V	322	M	CHLE_HUMAN	Polymorphism	754644618	A/B	V	294	M
28	UniProt	VAR_040031	L	335	P	CHLE_HUMAN	Disease (BChE deficiency)	104893684	A/B	L	307	P
29	UniProt	VAR_040032	A	356	D	CHLE_HUMAN	Disease (BChE deficiency)	770337031	A/B	A	328	D
30	UniProt	VAR_002362	L	358	I	CHLE_HUMAN	Disease (BChE deficiency)	121918557	A/B	L	330	I
31	UniProt	VAR_072100	G	361	C	CHLE_HUMAN	Disease (BChE deficiency)	---	A/B	G	333	C
32	UniProt	VAR_040033	G	393	R	CHLE_HUMAN	Disease (BChE deficiency)	115129687	A/B	G	365	R
33	UniProt	VAR_040034	R	414	C	CHLE_HUMAN	Disease (BChE deficiency)	745364489	A/B	R	386	C
34	UniProt	VAR_040035	G	418	V	CHLE_HUMAN	Disease (BChE deficiency)	28933390	A/B	G	390	V
35	UniProt	VAR_040036	F	446	S	CHLE_HUMAN	Disease (BChE deficiency)	---	A/B	F	418	S
36	UniProt	VAR_040037	E	488	K	CHLE_HUMAN	Disease (BChE deficiency)	200998515	A/B	E	460	K
37	UniProt	VAR_072101	R	498	W	CHLE_HUMAN	Polymorphism	115017300	A/B	R	470	W
38	UniProt	VAR_040038	W	499	R	CHLE_HUMAN	Disease (BChE deficiency)	---	A/B	W	471	R
39	UniProt	VAR_040039	F	502	L	CHLE_HUMAN	Disease (BChE deficiency)	769316835	A/B	F	474	L
40	UniProt	VAR_040040	E	525	V	CHLE_HUMAN	Disease (BChE deficiency)	121918556	A/B	E	497	V
41	UniProt	VAR_040041	R	543	C	CHLE_HUMAN	Disease (BChE deficiency)	199660374	A/B	R	515	C
42	UniProt	VAR_040042	Q	546	L	CHLE_HUMAN	Disease (BChE deficiency)	---	A/B	Q	518	L

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 1 (42, 336)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_072094	K	40	R	CHLE_HUMAN	Polymorphism	116047990	A/B	K	12	R
02	UniProt	VAR_040012	T	52	M	CHLE_HUMAN	Disease (BChE deficiency)	56309853	A/B	T	24	M
03	UniProt	VAR_040013	F	56	I	CHLE_HUMAN	Disease (BChE deficiency)	531738678	A/B	F	28	I
04	UniProt	VAR_040014	Y	61	C	CHLE_HUMAN	Disease (BChE deficiency)	116097205	A/B	Y	33	C
05	UniProt	VAR_072730	A	62	V	CHLE_HUMAN	Disease (BChE deficiency)	---	A/B	A	34	V
06	UniProt	VAR_040015	P	65	S	CHLE_HUMAN	Disease (BChE deficiency)	148170012	A/B	P	37	S
07	UniProt	VAR_002360	D	98	G	CHLE_HUMAN	Disease (BChE deficiency)	1799807	A/B	D	70	G
08	UniProt	VAR_040016	D	98	H	CHLE_HUMAN	Disease (BChE deficiency)	---	A/B	D	70	H
09	UniProt	VAR_072095	G	103	R	CHLE_HUMAN	Disease (BChE deficiency)	---	A/B	G	75	R
10	UniProt	VAR_072096	E	118	D	CHLE_HUMAN	Disease (BChE deficiency)	---	A/B	E	90	D
11	UniProt	VAR_040017	N	124	Y	CHLE_HUMAN	Disease (BChE deficiency)	---	A/B	N	96	Y
12	UniProt	VAR_072097	I	127	M	CHLE_HUMAN	Polymorphism	755600722	A/B	I	99	M
13	UniProt	VAR_040018	P	128	S	CHLE_HUMAN	Disease (BChE deficiency)	3732880	A/B	P	100	S
14	UniProt	VAR_040019	G	143	D	CHLE_HUMAN	Disease (BChE deficiency)	201820739	A/B	G	115	D
15	UniProt	VAR_040020	L	153	F	CHLE_HUMAN	Disease (BChE deficiency)	747598704	A/B	L	125	F
16	UniProt	VAR_040021	Y	156	C	CHLE_HUMAN	Disease (BChE deficiency)	121918558	A/B	Y	128	C
17	UniProt	VAR_040022	V	170	M	CHLE_HUMAN	Disease (BChE deficiency)	527843566	A/B	V	142	M
18	UniProt	VAR_040023	D	198	E	CHLE_HUMAN	Disease (BChE deficiency)	781368801	A/B	D	170	E
19	UniProt	VAR_040024	S	226	G	CHLE_HUMAN	Disease (BChE deficiency)	370077923	A/B	S	198	G
20	UniProt	VAR_040025	A	227	V	CHLE_HUMAN	Disease (BChE deficiency)	---	A/B	A	199	V
21	UniProt	VAR_040026	A	229	T	CHLE_HUMAN	Disease (BChE deficiency)	---	A/B	A	201	T
22	UniProt	VAR_072098	V	232	D	CHLE_HUMAN	Disease (BChE deficiency)	---	A/B	V	204	D
23	UniProt	VAR_040027	T	271	M	CHLE_HUMAN	Disease (BChE deficiency)	28933389	A/B	T	243	M
24	UniProt	VAR_040028	T	278	P	CHLE_HUMAN	Disease (BChE deficiency)	---	A/B	T	250	P
25	UniProt	VAR_040029	E	283	D	CHLE_HUMAN	Polymorphism	16849700	A/B	E	255	D
26	UniProt	VAR_040030	K	295	R	CHLE_HUMAN	Disease (BChE deficiency)	115624085	A/B	K	267	R
27	UniProt	VAR_072099	V	322	M	CHLE_HUMAN	Polymorphism	754644618	A/B	V	294	M
28	UniProt	VAR_040031	L	335	P	CHLE_HUMAN	Disease (BChE deficiency)	104893684	A/B	L	307	P
29	UniProt	VAR_040032	A	356	D	CHLE_HUMAN	Disease (BChE deficiency)	770337031	A/B	A	328	D
30	UniProt	VAR_002362	L	358	I	CHLE_HUMAN	Disease (BChE deficiency)	121918557	A/B	L	330	I
31	UniProt	VAR_072100	G	361	C	CHLE_HUMAN	Disease (BChE deficiency)	---	A/B	G	333	C
32	UniProt	VAR_040033	G	393	R	CHLE_HUMAN	Disease (BChE deficiency)	115129687	A/B	G	365	R
33	UniProt	VAR_040034	R	414	C	CHLE_HUMAN	Disease (BChE deficiency)	745364489	A/B	R	386	C
34	UniProt	VAR_040035	G	418	V	CHLE_HUMAN	Disease (BChE deficiency)	28933390	A/B	G	390	V
35	UniProt	VAR_040036	F	446	S	CHLE_HUMAN	Disease (BChE deficiency)	---	A/B	F	418	S
36	UniProt	VAR_040037	E	488	K	CHLE_HUMAN	Disease (BChE deficiency)	200998515	A/B	E	460	K
37	UniProt	VAR_072101	R	498	W	CHLE_HUMAN	Polymorphism	115017300	A/B	R	470	W
38	UniProt	VAR_040038	W	499	R	CHLE_HUMAN	Disease (BChE deficiency)	---	A/B	W	471	R
39	UniProt	VAR_040039	F	502	L	CHLE_HUMAN	Disease (BChE deficiency)	769316835	A/B	F	474	L
40	UniProt	VAR_040040	E	525	V	CHLE_HUMAN	Disease (BChE deficiency)	121918556	A/B	E	497	V
41	UniProt	VAR_040041	R	543	C	CHLE_HUMAN	Disease (BChE deficiency)	199660374	A/B	R	515	C
42	UniProt	VAR_040042	Q	546	L	CHLE_HUMAN	Disease (BChE deficiency)	---	A/B	Q	518	L

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Asymmetric Unit (2, 4)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	CARBOXYLESTERASE_B_2	PS00941	Carboxylesterases type-B signature 2.	CHLE_HUMAN	118-128	2	A:90-100 B:90-100
2	CARBOXYLESTERASE_B_1	PS00122	Carboxylesterases type-B serine active site.	CHLE_HUMAN	213-228	2	A:185-200 B:185-200

Biological Unit 1 (2, 16)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	CARBOXYLESTERASE_B_2	PS00941	Carboxylesterases type-B signature 2.	CHLE_HUMAN	118-128	8	A:90-100 B:90-100
2	CARBOXYLESTERASE_B_1	PS00122	Carboxylesterases type-B serine active site.	CHLE_HUMAN	213-228	8	A:185-200 B:185-200

Asymmetric Unit (3, 6)

	ENSEMBL					UniProtKB			PDB
No.	Transcript ID	Exon	Exon ID	Genome Location	Length	ID	Location	Length	Count	Location	Length
1.1a	ENST00000264381	1a	ENSE00001954521	chr3:165555260-165555102	159	CHLE_HUMAN	-	0	0	-	-
1.2	ENST00000264381	2	ENSE00000826111	chr3:165548829-165547305	1525	CHLE_HUMAN	1-506	506	2	A:4-478 (gaps) B:4-478 (gaps)	475 475
1.4	ENST00000264381	4	ENSE00000780132	chr3:165504099-165503933	167	CHLE_HUMAN	506-562	57	2	A:478-534 B:478-534	57 57
1.7c	ENST00000264381	7c	ENSE00001810445	chr3:165491294-165490692	603	CHLE_HUMAN	562-602	41	2	A:534-534 B:534-534	1 1

Asymmetric Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:530
 aligned with CHLE_HUMAN | P06276 from UniProtKB/Swiss-Prot  Length:602

    Alignment length:531
                                    41        51        61        71        81        91       101       111       121       131       141       151       161       171       181       191       201       211       221       231       241       251       261       271       281       291       301       311       321       331       341       351       361       371       381       391       401       411       421       431       441       451       461       471       481       491       501       511       521       531       541       551       561 
           CHLE_HUMAN    32 IIIATKNGKVRGMNLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDNYTKAEEILSRSIVKRWANFAKYGNPNETQNNSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKVLEMTG 562
               SCOP domains d2pm8a_ A: automated matches                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        SCOP domains
               CATH domains 2pm8A00 A:4-534  [code=3.40.50.1820, no name defined]                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               CATH domains
               Pfam domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .eeee..eeee.eeeee..eeeeeeeeee......................eee..................hhhhhh............eeeeeee......eeeeeee...........hhhhhhhhhhhhhh.eeeee....hhhhhh..........hhhhhhhhhhhhhhhhhhhhh.eeeeeeeeeeehhhhhhhhhhh..........eeeee...........hhhhhhhhhhhhhhhh.....hhhhhhhhhhh.hhhhhhhhhh........................hhhhhhhh.......eeeeee...hhhhhhhh............hhhhhhhhhhhhh...hhhhhhhhhhhhh........hhhhhhhhhhhhhhhhhhhhhhhhhhhhh....eeeeee.........hhhhh.....hhhhhhhhhhh...-.hhhhhhhhhhhhhhhhhhhhhh....................eeeee......eee..hhhhhhhhhhhhhhhhhh.. Sec.struct. author
             SAPs(SNPs) (1) --------R-----------M---I----CV--S--------------------------------G----R--------------D-----Y--MS--------------D---------F--C-------------M---------------------------E---------------------------GV-T--D--------------------------------------M------P----D-----------R--------------------------M------------P--------------------D-I--C-------------------------------R--------------------C---V---------------------------S-----------------------------------------K---------WR--L----------------------V-----------------C--L---------------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ------------------------------------------------------------------H-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (2)
                    PROSITE --------------------------------------------------------------------------------------CARBOXYLEST------------------------------------------------------------------------------------CARBOXYLESTERASE---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.2  PDB: A:4-478 (gaps) UniProt: 1-506 [INCOMPLETE]                                                                                                                                                                                                                                                                                                                                                                                                                                  -------------------------------------------------------1 Transcript 1 (1)
           Transcript 1 (2) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Exon 1.4  PDB: A:478-534 UniProt: 506-562                 Transcript 1 (2)
                 2pm8 A   4 IIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRD-YTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKVLEMTG 534
                                    13        23        33        43        53        63        73        83        93       103       113       123       133       143       153       163       173       183       193       203       213       223       233       243       253       263       273       283       293       303       313       323       333       343       353       363       373       383       393       403       413       423       433       443       453| |    463       473       483       493       503       513       523       533 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            454 |                                                                              
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              456

Chain B from PDB  Type:PROTEIN  Length:530
 aligned with CHLE_HUMAN | P06276 from UniProtKB/Swiss-Prot  Length:602

    Alignment length:531
                                    41        51        61        71        81        91       101       111       121       131       141       151       161       171       181       191       201       211       221       231       241       251       261       271       281       291       301       311       321       331       341       351       361       371       381       391       401       411       421       431       441       451       461       471       481       491       501       511       521       531       541       551       561 
           CHLE_HUMAN    32 IIIATKNGKVRGMNLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDNYTKAEEILSRSIVKRWANFAKYGNPNETQNNSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKVLEMTG 562
               SCOP domains d2pm8b_ B: automated matches                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        SCOP domains
               CATH domains 2pm8B00 B:4-534  [code=3.40.50.1820, no name defined]                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               CATH domains
           Pfam domains (1) COesterase-2pm8B01 B:4-522                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             ------------ Pfam domains (1)
           Pfam domains (2) COesterase-2pm8B02 B:4-522                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             ------------ Pfam domains (2)
         Sec.struct. author .eeee..eeee.eeeee..eeeeeeeeee.....hhhhh............eee..................hhhhhh............eeeeeee......eeeeeee...........hhhhhhhhhhhhhh.eeeee....hhhhhh..........hhhhhhhhhhhhhhhhhhhhh.eeeeeeeeeehhhhhhhhhhhh.hhhhh....eeeee...........hhhhhhhhhhhhhhhh......hhhhhhhhh..hhhhhhhhhh........................hhhhhhhh.......eeeeee.hhhhhhhhhh............hhhhhhhhhhhhh...hhhhhhhhhhhhh........hhhhhhhhhhhhhhhhhhhhhhhhhhhhh....eeeeee.........hhhhh.....hhhhhhhhhhh...-.hhhhhhhhhhhhhhhhhhhhhh....................eeeee......eee..hhhhhhhhhh.hhhhhhhhh Sec.struct. author
             SAPs(SNPs) (1) --------R-----------M---I----CV--S--------------------------------G----R--------------D-----Y--MS--------------D---------F--C-------------M---------------------------E---------------------------GV-T--D--------------------------------------M------P----D-----------R--------------------------M------------P--------------------D-I--C-------------------------------R--------------------C---V---------------------------S-----------------------------------------K---------WR--L----------------------V-----------------C--L---------------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ------------------------------------------------------------------H-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (2)
                    PROSITE --------------------------------------------------------------------------------------CARBOXYLEST------------------------------------------------------------------------------------CARBOXYLESTERASE---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.2  PDB: B:4-478 (gaps) UniProt: 1-506 [INCOMPLETE]                                                                                                                                                                                                                                                                                                                                                                                                                                  -------------------------------------------------------1 Transcript 1 (1)
           Transcript 1 (2) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Exon 1.4  PDB: B:478-534 UniProt: 506-562                 Transcript 1 (2)
                 2pm8 B   4 IIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRD-YTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKVLEMTG 534
                                    13        23        33        43        53        63        73        83        93       103       113       123       133       143       153       163       173       183       193       203       213       223       233       243       253       263       273       283       293       303       313       323       333       343       353       363       373       383       393       403       413       423       433       443       453| |    463       473       483       493       503       513       523       533 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            454 |                                                                              
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              456

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

Asymmetric Unit

Classes(

)

Folds(

)

Superfamilies( (-)

)

Families(

)

Protein Domains( (-)

)

Organisms( (-)

)

Class: Alpha and beta proteins (a/b) (23833)

Fold: alpha/beta-Hydrolases (971)

Superfamily: alpha/beta-Hydrolases (971)

Family: automated matches (184)

Protein domain: automated matches (184)

Human (Homo sapiens) [TaxId: 9606] (42)

1a	d2pm8a_	A:
1b	d2pm8b_	B:

Asymmetric Unit

Classes(

)

Architectures( (-)

)

Topologies( (-)

)

Homologous Superfamilies( (-)

)

Organisms( (-)

)

Class: Alpha Beta (26913)

Architecture: 3-Layer(aba) Sandwich (12045)

Topology: Rossmann fold (7312)

Homologous Superfamily: [code=3.40.50.1820, no name defined] (692)

Human (Homo sapiens) (118)

1a	2pm8A00	A:4-534
1b	2pm8B00	B:4-534

Asymmetric Unit

Clans(

)

Families(

)

Organisms( (-)

)

Clan: AB_hydrolase (347)

Family: COesterase (79)

Homo sapiens (Human) (38)

1a	COesterase-2pm8B01	B:4-522
1b	COesterase-2pm8B02	B:4-522

Asymmetric Unit(hide GO term definitions)

Chain A,B (CHLE_HUMAN | P06276)

molecular function
	GO:0003990	acetylcholinesterase activity	Catalysis of the reaction: acetylcholine + H2O = choline + acetate.
	GO:0001540	amyloid-beta binding	Interacting selectively and non-covalently with amyloid-beta peptide/protein and/or its precursor.
	GO:0052689	carboxylic ester hydrolase activity	Catalysis of the hydrolysis of a carboxylic ester bond.
	GO:0003824	catalytic activity	Catalysis of a biochemical reaction at physiological temperatures. In biologically catalyzed reactions, the reactants are known as substrates, and the catalysts are naturally occurring macromolecular substances known as enzymes. Enzymes possess specific binding sites for substrates, and are usually composed wholly or largely of protein, but RNA that has catalytic activity (ribozyme) is often also regarded as enzymatic.
	GO:0033265	choline binding	Interacting selectively and non-covalently with choline, the amine 2-hydroxy-N,N,N-trimethylethanaminium.
	GO:0004104	cholinesterase activity	Catalysis of the reaction: an acylcholine + H2O = choline + a carboxylic acid anion.
	GO:0019899	enzyme binding	Interacting selectively and non-covalently with any enzyme.
	GO:0016787	hydrolase activity	Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.
	GO:0016788	hydrolase activity, acting on ester bonds	Catalysis of the hydrolysis of any ester bond.
	GO:0042802	identical protein binding	Interacting selectively and non-covalently with an identical protein or proteins.
biological process
	GO:0019695	choline metabolic process	The chemical reactions and pathways involving choline (2-hydroxyethyltrimethylammonium), an amino alcohol that occurs widely in living organisms as a constituent of certain types of phospholipids and in the neurotransmitter acetylcholine.
	GO:0050783	cocaine metabolic process	The chemical reactions and pathways involving cocaine, an alkaloid obtained from the dried leaves of the shrub Erythroxylon coca. It is a cerebral stimulant and narcotic.
	GO:0007612	learning	Any process in an organism in which a relatively long-lasting adaptive behavioral change occurs as the result of experience.
	GO:0008285	negative regulation of cell proliferation	Any process that stops, prevents or reduces the rate or extent of cell proliferation.
	GO:0050805	negative regulation of synaptic transmission	Any process that stops, prevents, or reduces the frequency, rate or extent of synaptic transmission, the process of communication from a neuron to a target (neuron, muscle, or secretory cell) across a synapse.
	GO:0014016	neuroblast differentiation	The process in which a relatively unspecialized cell acquires specialized features of a neuroblast. There are at least four stages through which the pluripotent cells of epiblast or blastula become neuroblasts.
	GO:0043279	response to alkaloid	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an alkaloid stimulus. Alkaloids are a large group of nitrogenous substances found in naturally in plants, many of which have extracts that are pharmacologically active.
	GO:0042493	response to drug	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
	GO:0051593	response to folic acid	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a folic acid stimulus.
	GO:0051384	response to glucocorticoid	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucocorticoid stimulus. Glucocorticoids are hormonal C21 corticosteroids synthesized from cholesterol with the ability to bind with the cortisol receptor and trigger similar effects. Glucocorticoids act primarily on carbohydrate and protein metabolism, and have anti-inflammatory effects.
	GO:0007584	response to nutrient	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nutrient stimulus.
cellular component
	GO:0072562	blood microparticle	A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids.
	GO:0005783	endoplasmic reticulum	The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
	GO:0005788	endoplasmic reticulum lumen	The volume enclosed by the membranes of the endoplasmic reticulum.
	GO:0005576	extracellular region	The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
	GO:0005615	extracellular space	That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
	GO:0016020	membrane	A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
	GO:0005641	nuclear envelope lumen	The region between the two lipid bilayers of the nuclear envelope; 20-40 nm wide.

Asymmetric Unit
	Complete Structure
		Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
		WebMol \| AstexViewer[tm]@PDBe (Java Applets, require no local installation except for Java; loading may be slow)
		STRAP (Java WebStart application, automatic local installation, requires Java; full application with system access!)
		RasMol (require local installation)
		Molscript (VRML) (requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)

	Ligands, Modified Residues, Ions
		GOL	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		NAG	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		NDG	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		SO4	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]

	Sites
		AC1	[ RasMol ]	+environment [ RasMol ]
		AC2	[ RasMol ]	+environment [ RasMol ]
		AC3	[ RasMol ]	+environment [ RasMol ]
		AC4	[ RasMol ]	+environment [ RasMol ]
		AC5	[ RasMol ]	+environment [ RasMol ]
		AC6	[ RasMol ]	+environment [ RasMol ]
		AC7	[ RasMol ]	+environment [ RasMol ]
		AC8	[ RasMol ]	+environment [ RasMol ]
		AC9	[ RasMol ]	+environment [ RasMol ]
		BC1	[ RasMol ]	+environment [ RasMol ]
		BC2	[ RasMol ]	+environment [ RasMol ]
		BC3	[ RasMol ]	+environment [ RasMol ]
		BC4	[ RasMol ]	+environment [ RasMol ]
		BC5	[ RasMol ]	+environment [ RasMol ]
		BC6	[ RasMol ]	+environment [ RasMol ]
		BC7	[ RasMol ]	+environment [ RasMol ]
		BC8	[ RasMol ]	+environment [ RasMol ]
		BC9	[ RasMol ]	+environment [ RasMol ]
		CC1	[ RasMol ]	+environment [ RasMol ]

	Cis Peptide Bonds
		Ala A:101 - Pro A:102	[ RasMol ]
		Ala B:101 - Pro B:102	[ RasMol ]
		Pro A:104 - Lys A:105	[ RasMol ]
		Pro B:104 - Lys B:105	[ RasMol ]

Biological Unit
	Complete Structure
		Biological Unit 1	[ Jena3D ]

Jmol
	protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick [ Asym. Unit PNG format \| Asym. Unit - sites PNG format \| Biol. Unit 1 PNG format \| Biol. Unit 1 - sites PNG format ](automatic orientation, automatically generated)
Molscript
	protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick [ mono PDF format \| stereo PDF format ](default orientation, automatically generated)

Access by PDB/NDB ID
	2pm8
		Family and Domain Information	:	ProDom \| SYSTERS
		General Structural Information	:	GlycoscienceDB \| MMDB \| NDB \| OCA \| PDB \| PDBe \| PDBj \| PDBsum \| PDBWiki \| PQS \| PROTEOPEDIA
		Orientation in Membranes	:	OPM
		Protein Surface	:	SURFACE
		Secondary Structure	:	DSSP (structure derived) \| HSSP (homology derived)
		Structural Genomics	:	GeneCensus
		Structural Neighbours	:	CE \| VAST
		Structure Classification	:	CATH \| Dali \| SCOP
		Validation and Original Data	:	BMRB Data View \| BMRB Restraints Grid \| EDS \| PROCHECK \| RECOORD \| WHAT_CHECK

Access by UniProt ID/Accession number
	CHLE_HUMAN \| P06276
		Comparative Protein Structure Models	:	ModBase
		Genomic Information	:	Ensembl
		Protein-protein Interaction	:	DIP
		Sequence, Family and Domain Information	:	InterPro \| Pfam \| SMART \| UniProtKB/SwissProt

Access by Enzyme Classificator (EC Number)
	3.1.1.8
		General Enzyme Information	:	BRENDA \| EC-PDB \| Enzyme \| IntEnz
		Pathway	:	KEGG \| MetaCyc

Access by Disease Identifier (MIM ID)
	177400
		Disease Information	:	OMIM

Access by GenAge ID
	(no 'GenAge ID' available)
		Age Related Information	:	GenAge

Access by PDB/NDB ID
		Domain Information	:	XDom
		Interatomic Contacts of Structural Units	:	CSU
		Ligand-protein Contacts	:	LPC
		Protein Cavities	:	castP
		Sequence and Secondary Structure	:	PDBCartoon
		Structure Alignment	:	STRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
		Structure and Sequence Browser	:	STING

Access by UniProt ID/Accession number
	CHLE_HUMAN \| P06276
		Protein Disorder Prediction	:	DisEMBL \| FoldIndex \| GLOBPLOT (for more information see DisProt)

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (4, 19)

Sites (19, 19)

SS Bonds (6, 6)

Cis Peptide Bonds (4, 4)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (42, 84)

PROSITE Motifs (2, 4)

Exons (3, 6)

Sequences/Alignments

Classification and Annotation

SCOP Domains (1, 2)

CATH Domains (1, 2)

Pfam Domains (1, 2)

Gene Ontology (28, 28)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File